Legal information Personal data protection policy

LEGAL NOTICE

Access to and use of this website (hereinafter the “Site”) are subject to the legal provisions in force as well as to the present conditions. By accessing and browsing this Site, the user acknowledges having read and agrees to be bound, without restriction or reservation, to all the present terms and conditions, and to comply with them.

Editor:

OSE Immunotherapeutics

A public limited company

Share capital: 3,657,007.60 €

Headquarters: 22 Boulevard Benoni Goullin, 44200 Nantes, France

Registered with the Nantes Trade Register under the number 479 457 715

Host: OVH – 2 rue Kellermann – BP 80157 – 59100 Roubaix ; téléphone : 1007

Publication Director: Dominique Costantini, Chief Executive Officer

Publication Co-Director: Sylvie Détry, Communication Manager

Photo credits/Illustrations:  OSE Immunotherapeutics22, boulevard Bénoni Goullin – 44200 Nantes

Objective and quality of contentThe purpose of the Site is to inform the general public, professionals, investors and the media. OSE Immunotherapeutics SA (hereinafter “OSE”) strives to provide quality and verified information, however if any information appeared inaccurate or contains a typographical error, you can report it to the site administrator.

Nature of the information

Information supplied on the Site is for information purposes only and may expressly or implicitly contain certain forward-looking statements concerning OSE and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of OSE Immunotherapeutics to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. OSE does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise. For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of OSE to differ from those contained in the forward-looking statements, please refer to the OSE’s Universal Registration Document(s) filed with the AMF, including the annual financial report, available on the SSite.

Intellectual property

The Site is owned and exploited by OSE. The Site and all the elements and documents contained in it (the general presentation, texts, images, brands, logos, or any other element of the Site) are the property of OSE or have been the subject of prior authorization for use.No element of the Site may be copied, modified, transmitted, republished or used in any way whatsoever, in whole or in part, for commercial purposes, without the prior written authorization of OSE.The creation of hypertext links to the Site is subject to the prior written consent of OSE.

Links to other websites

In order to facilitate access to other websites that may provide additional information, OSE may establish a number of links on the Site. OSE cannot be held liable for a third-party site to which you have access via the Site. OSE has no means of controlling the content of these third-party sites which remain entirely independent of OSE.

Absence of Representation or warranty

Use of the Site is carried out at the sole risk of the user. OSE cannot be held responsible for any direct or indirect damage that may result from access to the Site, from its use, or from damage or viruses that could affect your computer or any other computer equipment. In addition, OSE endeavours to update the information contained on its Site. However, OSE gives no warranty or representation as to the accuracy of the information and cannot be held liable for any inaccuracy or omission in the content of the Site.

Site availability

OSE reserves the right to modify the content of the Site at any time and without notice. OSE may in particular suspend or interrupt, temporarily or permanently, all or part of the Site to carry out maintenance operations, improvements and / or modifications.

Confidentiality Policy

This Site is not intended to be a tool to receive your confidential information. Consequently, and except for the personal data mentioned below, any information, whatever its form (document, data, graphic, question, suggestion, concept, comment or other) that you may communicate to us through the Site or the contact address will not be considered confidential. Therefore, by communicating any such information to us you grant us the right to use, reproduce, publish, modify or transmit them in order to process your request, in accordance with the legal provisions in force.

Personal Data Protection Policy

 Collection and storage of personal data as well as type and purpose of data usage

a) When registering for our newsletters: If you want to receive our newsletters and have expressly consented during the registration process, we will use your e-mail address to send you our newsletter on a regular basis and exclusively for this purpose. Your email address will not be shared with any third party except with the supplier in charge of our Site maintenance who is subject to confidentiality obligations. At any time, you can revoke your consent to the storage of your data and its use for sending newsletters.

b) When using the email contact@ose-immuno.com and contact form: If you have any questions, we offer you the opportunity to contact us using the contact email provided on the Site. By using our contact email address, you give an express consent to OSE Immunotherapeutics to store, process and use your data exclusively to address your request.

The present data processing does not include data transfer outside the European Union.No automated decision-making is carried out on the data processing.

Cookies

A “cookie” is a series of information, generally small and identified by a name, which can be transmitted to your browser by a website on which you connect. Your web browser will keep it for a certain period of time and will send it back to the web server each time you connect to it again. Cookies that are strictly necessary for the site to function allow the main services of the site to function optimally. You can technically block them using your browser settings, but your experience on the Site may be degraded.

By using the ose-immuno.com Site, a temporary functional cookie, which does not contain any personal data, is created to determine whether the visitor’s browser accepts cookies. During each connection, a functional cookie linked to the language setting is set in order to save the display language preference information, which has a lifespan of 13 months.

Analysis tools

To maintain our mailing list (removal of invalid email address, ensuring deletion of potential unsubscriptions) and to evaluate the interest of our newsletters, we automatically track the reception of our emails. The information we gather are the following:

  • If the newsletter email has been received by each subscriber. In case the email bounced several times, we reserve the right to remove it from the mailing list. In general, emails bounce when they are either inaccurate (spelling mistake in the address provided) or when the mailbox is full indicating, over a period of time, that the email is not valid anymore.
  • To assess the quality and interest of the information we shared, we also gather, using pixel and click tracking, if our subscribers are opening our newsletters and click on the links provided within.

 

Data Security

OSE uses suitable technical and organizational security measures, in accordance with the state of the art, to protect your data against accidental or intentional manipulation, partial or complete loss, destruction or unauthorized access by third parties. Our security measures are continuously improved in line with technological developments.

 Name and contact details of the Company’s Data Protection Officer

The information relating to data protection is applicable to the data processing procedures observed by: OSE Immunotherapeutics SA, 22 boulevard Benoni Goullin, 44200 Nantes, France. OSE has appointed a Data Protection Officer who can be contacted by sending an email to  data-privacy@ose-immuno.com.

Rights of the data subject

At any time, you have the right to request information about your personal data processed by us as well as the correction of incorrect data or the deletion of your personal data. You may also request to restrict or stop the processing of your personal data, to receive the personal data that you have provided to us in a structured, current and machine-readable format. To use your right, just send an e-mail to data-privacy@ose-immuno.com.If necessary and at any time, you have the possibility to lodge a complaint with the CNIL, https://www.cnil.fr/fr/plaintes.

This data protection declaration is currently valid. Due to the future development of our Site and the offers above or to changes in legal or official requirements, it may be necessary to amend this data protection declaration. You can access the most recent version of the data protection declaration from this Site at any time and print it out. 

Applicable law

These terms and the use of this Site are governed by French law, to the exclusion of all other laws. French courts have territorial jurisdiction to hear any dispute relating to the application, interpretation or execution of the Terms of Use.

To receive OSE Immunotherapeutics’ latest news